Levetiracetam 500 mg

Levetiracetam 500 mg

Levetiracetam (INN) ( /lɛvɨtɪˈræsɨtæm/) is an anticonvulsant medication used to treat epilepsy.It is the S-enantiomer of etiracetam, structurally similar to the prototypical nootropic drug piracetam.  Levetiracetam is marketed under the trade name Keppra. Keppra is manufactured by UCB Pharmaceuticals Inc. Since November 2008 the drug has been available as a generic brand in the United States. Levetiracetam has been approved in the European Union as a monotherapy treatment for epilepsy in the case of partial seizures, or as an adjunctive therapy for partial, myoclonic and tonic-clonic seizures. It is also used in veterinary medicine for similar purposes. Levetiracetam has potential benefits for other psychiatric and neurologic conditions such as Tourette syndrome, Alzheimer's Disease, autism, bipolar disorder and anxiety disorder.[citation needed] However, its most serious adverse effects are behavioral, and its benefit-risk ratio in these conditions is not well understood. Along with other anticonvulsants like gabapentin, it is also sometimes used to treat neuropathic pain. It has not been found to be useful for essential tremors.

Levetiracetam 500 mg

Levetiracetam 500 mg

Levetiracetam 500 mg

Levetiracetam 500 mg

Levetiracetam 500 mg

Levetiracetam 500 mg

Levetiracetam 500 mg

Levetiracetam 500 mg

Levetiracetam 500 mg